The global IVD Quality Control market is projected to grow from USD 1.65 billion in 2025 to USD 2.15 billion by 2030, at a CAGR of 5.5%. This growth reflects the increasing emphasis on laboratory accreditation, quality assurance, and standardized testing practices worldwide. As diagnostic accuracy becomes a cornerstone of modern healthcare, how are laboratories ensuring consistent and reliable results?
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582
What is driving the demand for IVD quality control solutions?
The rising number of accredited clinical laboratories and the growing importance of external quality assessment (EQA) programs are key factors supporting market expansion. Laboratories are increasingly required to comply with stringent standards set by regulatory bodies such as International Organization for Standardization, College of American Pathologists, and Clinical Laboratory Improvement Amendments. These requirements are driving the adoption of robust quality control systems to ensure accuracy, reproducibility, and compliance.
Why are third-party controls dominating the market?
Third-party quality controls accounted for the largest share in 2024 due to their flexibility and independence from instrument manufacturers. These controls are compatible across multiple platforms and reagent lots, offering laboratories cost efficiency, longer shelf life, and consistent analyte stability. Additionally, they provide unbiased performance evaluation, which is critical for regulatory compliance and benchmarking through EQA programs.
Which end users are driving the fastest growth?
Clinical laboratories are expected to witness the highest growth during the forecast period. The increasing volume of diagnostic testing, combined with the adoption of advanced technologies such as molecular diagnostics and high-throughput systems, is driving demand for reliable quality control solutions. Laboratories are prioritizing accuracy and operational efficiency, leading to increased adoption of multianalyte QC products and data management solutions.
How is technology shaping the market landscape?
The integration of automated diagnostic platforms, immunoassays, and molecular diagnostics is enhancing testing capabilities while increasing the need for precise quality control. As testing complexity grows, laboratories are investing in advanced QC solutions to maintain consistency across diverse diagnostic workflows.
Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=198032582
Regional Insights:
Why does North America lead the market? North America holds the largest share of the IVD quality controls market, supported by its advanced healthcare infrastructure and strong regulatory environment. High diagnostic testing volumes, widespread adoption of automated systems, and a strong focus on compliance and quality assurance are driving demand for QC solutions in the region. Additionally, the presence of major industry players and continuous innovation further reinforce the region’s leadership position.
Market Insights:
Key players in the IVD quality controls market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Sysmex Corporation, and Randox Laboratories Ltd., among others. These companies are focusing on innovation, product expansion, and strategic partnerships to strengthen their market presence.
As quality assurance becomes increasingly critical in diagnostic workflows, stakeholders must invest in advanced QC solutions and compliance-driven strategies. To gain comprehensive insights into market trends, competitive dynamics, and growth opportunities, access the full report today.